Skip to main
IVVD

Invivyd Inc (IVVD) Stock Forecast & Price Target

Invivyd Inc (IVVD) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Invivyd Inc. is positioned favorably within the lucrative biopharmaceutical market, particularly following the significant revenue generation of approximately $56 billion from mRNA COVID-19 vaccines in 2022. The company's lead candidate, VYD2311, is currently undergoing a Phase 3 trial program called REVOLUTION, which, if successful, could substantially expand its target market and potentially validate the efficacy of monoclonal antibodies over existing mRNA vaccines. Additionally, continued advancement in the development of VYD2311 and other monoclonal antibody candidates underscores Invivyd's commitment to addressing serious viral infections, which may enhance its competitive standing in the rapidly evolving therapeutic landscape.

Bears say

The negative outlook on Invivyd Inc.'s stock is primarily driven by the substantial decrease in the efficacy of its lead product, PEMGARDA, against the omicron variant, which was found to be approximately 200-fold lower in the STAMP trial. Additionally, the diminished protective levels of mRNA vaccines in vulnerable populations, such as the elderly and immunocompromised, further reduce the commercial viability of Invivyd's mAb therapies in addressing the needs of these key demographics. Compounding these challenges, the ongoing decline in COVID-19 vaccination rates, alongside decreasing influenza vaccination rates, significantly shrinks the overall market opportunity for the company.

Invivyd Inc (IVVD) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Invivyd Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Invivyd Inc (IVVD) Forecast

Analysts have given Invivyd Inc (IVVD) a Strong Buy based on their latest research and market trends.

According to 4 analysts, Invivyd Inc (IVVD) has a Strong Buy consensus rating as of Apr 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $8, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $8, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Invivyd Inc (IVVD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.